R&D Hubs

Together with further specialized R&D sites around the world, we create a global network that fosters collaboration, curiosity and innovation.

Highly connected

By structuring all research and development activities of our Healthcare business around four well-connected hubs with more than 3,000 employees globally, we strengthen internal networking and facilitate external partnerships. At the same time these centers of excellence represent key markets for the company and allow us to tap into a concentration of scientific talent from local universities and life sciences companies. Together with further specialized R&D sites around the world, we create a global network that fosters collaboration, curiosity and innovation.

Darmstadt, Germany

More than 1,500 scientists and clinical development professionals work at our Darmstadt hub. It concentrates on research and development activities in immunology and oncology and is located on site at our corporate headquarters. This leads to collaborations and inspiring synergies with other business units. An enduring commitment to innovation throughout the site drives our efforts to discover promising new molecules and develop them into medicines that improve the lives of patients, physicians and caregivers. Our network of partnerships with other biotech companies and academic groups based in and around Germany fosters a constant flow of new ideas into our company.

Boston, USA

Our US hub is located at the EMD Serono Research and Development Institute in Billerica, Massachusetts, northwest of Boston. At this state-of-the-art facility more than 500 scientists and clinical development professionals focus on neurology, immunology, immuno-oncology and oncology. With close collaboration across all R&D teams working at this hub, we are strengthening its synergies to discover and advance innovative therapies that address high medical needs. This center of excellence is designed to attract the very best scientific talent and underpin a broad range of partnerships with US-based companies, academic centers and key opinion leaders, especially in Boston where the life sciences community is exceptionally vibrant.

Beijing, China

The Beijing hub is crucial to our vision of expanding in Asia. Our Healthcare business uniquely combines the assets of a leading science and technology pioneer with a deep-rooted tradition in pharmaceutical science – both are highly regarded in China. Research activities at the Beijing hub focus mainly on biomarker research, including pharmacogenomics and bioanalytics.

The professional development of the more than 150 employees based here is a key priority for us. We foster their talent and curiosity with world-class training on cutting-edge research topics and technologies, and provide them with opportunities to interact with renowned scientists and clinical experts based in China. By leading drug development for local clinical trials and by participating in global clinical trials from Beijing, we can leverage our expertise to liaise more effectively with government stakeholders, academic institutions and other research-oriented organizations.

Tokyo, Japan

Our Tokyo hub focuses on oncology, immunology and endocrinology. It serves as our gateway to our broader North East Asian Hub (NEAH), which includes Japan, Taiwan, Korea, Hong Kong, Singapore, Indonesia and Thailand. North East Asia is a significant focus area for our Healthcare business. Not only is this region primed for investment and meaningful growth in scientific innovation, but it also experiences high levels of unmet medical needs, especially in diseases particularly prevalent in Asia such as gastric cancer. More than 60 employees located at this hub are contributing to strengthening our presence in North East Asia and delivering differentiated medicines to patients in need.


You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement